IMM 1.72% 29.5¢ immutep limited

abagovomab fails placebo phase111 trial, page-32

  1. 2,027 Posts.
    Boiler, here is your task.

    Go to PubMed (given your obvious knowledge of research you will know what I am talking about) and do a search on abagovomab.

    Read each abstract.

    Find a pure Phase 2 study for me.

    I cannot.

    All I can find is this:

    "An overview of abagovomab, generation and mechanism of action, Phase I/II results and the status of the Phase II/III ongoing trial is given"

    Sometimes companies roll a preliminary Phase 2 into a Phase 1 and then roll a further Phase 2 into a Phase 3 to save money and progress things faster, but this approach obviously carries more risk.

    Do your research.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $428.5M
Open High Low Value Volume
28.5¢ 30.5¢ 28.5¢ $469.8K 1.579M

Buyers (Bids)

No. Vol. Price($)
9 297652 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 7500 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.